On the public citation graph
Drug Target Commons 2.0: a community platform for systematic analysis of drug–target interaction profiles
0 signed · 117 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2011.746openalex-snapshot
KIT as a Therapeutic Target in Metastatic Melanoma
inferredcites →https://doi.org/10.1007/s10637-011-9763-9openalex-snapshot
Nilotinib in patients with metastatic melanoma harboring KIT gene aberration
inferredcites →https://doi.org/10.1016/j.cell.2016.01.045openalex-snapshot
Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution
inferredcites →https://doi.org/10.1016/j.chembiol.2017.11.004openalex-snapshot
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
inferredcites →https://doi.org/10.1016/j.chembiol.2017.11.009openalex-snapshot
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions
inferredcites →https://doi.org/10.1016/j.ddtec.2015.01.005openalex-snapshot
Chemical databases: curation or integration by user-defined equivalence?
inferredcites →https://doi.org/10.1016/j.drudis.2012.05.016openalex-snapshot
Open PHACTS: semantic interoperability for drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2015.08.001openalex-snapshot
Identifying compound efficacy targets in phenotypic drug discovery
inferredcites →https://doi.org/10.1016/j.leukres.2008.09.027openalex-snapshot
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V
inferredcites →https://doi.org/10.1038/nature08506openalex-snapshot
Predicting new molecular targets for known drugs
inferredcites →https://doi.org/10.1038/nature14119openalex-snapshot
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
inferredcites →https://doi.org/10.1038/nbt1228openalex-snapshot
Global mapping of pharmacological space
inferredcites →https://doi.org/10.1038/nchembio.1867openalex-snapshot
The promise and peril of chemical probes
inferredcites →https://doi.org/10.1038/ncomms12846openalex-snapshot
Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
inferredcites →https://doi.org/10.1038/nmeth.4457openalex-snapshot
The inconvenience of data of convenience: computational research beyond post-mortem analyses
inferredcites →https://doi.org/10.1038/nrd.2016.230openalex-snapshot
A comprehensive map of molecular drug targets
inferredcites →https://doi.org/10.1039/b905821bopenalex-snapshot
The topology of drug–target interaction networks: implicit dependence on drug properties and target families
inferredcites →https://doi.org/10.1080/17460441.2018.1413089openalex-snapshot
Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
inferredcites →https://doi.org/10.1093/database/baw041openalex-snapshot
The drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development
inferredcites →https://doi.org/10.1093/nar/27.1.29openalex-snapshot
KEGG: Kyoto Encyclopedia of Genes and Genomes
inferredcites →https://doi.org/10.1093/nar/28.1.27openalex-snapshot
KEGG: Kyoto Encyclopedia of Genes and Genomes
inferredcites →https://doi.org/10.1093/nar/30.1.163openalex-snapshot
PharmGKB: the Pharmacogenetics Knowledge Base
inferredcites →https://doi.org/10.1093/nar/gkj067openalex-snapshot
DrugBank: a comprehensive resource for in silico drug discovery and exploration
inferredcites →https://doi.org/10.1093/nar/gkr777openalex-snapshot
ChEMBL: a large-scale bioactivity database for drug discovery
inferredcites →https://doi.org/10.1093/nar/gkv1072openalex-snapshot
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
inferredcites →https://doi.org/10.1093/nar/gkv1165openalex-snapshot
DGIdb 2.0: mining clinically relevant drug–gene interactions
inferredcites →https://doi.org/10.1093/nar/gkv1230openalex-snapshot
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information
inferredcites →https://doi.org/10.1093/nar/gkv1277openalex-snapshot
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
inferredcites →https://doi.org/10.1093/nar/gkw943openalex-snapshot
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
inferredcites →https://doi.org/10.1093/nar/gkx384openalex-snapshot
C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms
inferredcites →https://doi.org/10.1111/bph.13882openalex-snapshot
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview
inferredcites →https://doi.org/10.1111/bph.13883openalex-snapshot
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters
inferredcites →https://doi.org/10.1126/science.aan4368openalex-snapshot
The target landscape of clinical kinase drugs
inferredcites →https://doi.org/10.1158/0008-5472.can-17-3644openalex-snapshot
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-1987openalex-snapshot
Sunitinib Therapy for Melanoma Patients with KIT Mutations
inferredcites →https://doi.org/10.1182/blood-2009-03-208298openalex-snapshot
Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation
inferredcites →https://doi.org/10.1182/blood-2011-06-363960openalex-snapshot
Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
inferredcites →https://doi.org/10.1186/2041-1480-5-s1-s5openalex-snapshot
Evolving BioAssay Ontology (BAO): modularization, integration and applications
inferredcites →https://doi.org/10.1186/s12859-017-1785-7openalex-snapshot
MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selection
inferredcites →https://doi.org/10.1186/s13073-018-0531-8openalex-snapshot
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
inferredcites →https://doi.org/10.1200/jco.2007.14.0707openalex-snapshot
Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
inferredcites →https://doi.org/10.1200/jco.2010.28.9678openalex-snapshot
Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
inferredcites →https://doi.org/10.1200/jco.2010.33.9275openalex-snapshot
Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification
inferredcites →https://doi.org/10.1371/journal.pcbi.1005678openalex-snapshot
Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cjce.23873openalex-snapshot
An ontology‐based procedure knowledge framework for the process industry
inferred← citeshttps://doi.org/10.1002/wcms.1597openalex-snapshot
Deep learning for drug repurposing: Methods, databases, and applications
inferred← citeshttps://doi.org/10.1007/978-3-030-45688-7_28openalex-snapshot
Ontology Learning Approach Based on Analysis of the Context and Metadata of a Weakly Structured Content
inferred← citeshttps://doi.org/10.1007/978-3-030-52152-3_5openalex-snapshot
The Dynamics of Growing Symbols: A Ludics Approach to Language Design by Autonomous Agents
inferred← citeshttps://doi.org/10.1007/978-3-030-55035-6_17openalex-snapshot
Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_19openalex-snapshot
Databases for Rational Design and Discovery of Multitarget Drugs
inferred← citeshttps://doi.org/10.1007/978-981-15-3380-8_30openalex-snapshot
Use of Ontology Learning in Information System Integration: A Literature Survey
inferred← citeshttps://doi.org/10.1007/978-981-92-0477-9_17openalex-snapshot
Role of AI and Machine Learning in Designing Next-Generation Therapeutics
inferred← citeshttps://doi.org/10.1007/s00044-025-03465-7openalex-snapshot
Comparative analysis on artificial intelligence methods for DTI and DTBA prediction in drug repurposing
inferred← citeshttps://doi.org/10.1007/s10822-025-00717-xopenalex-snapshot
DeepTargetClass: a web-based platform for predicting protein target classes of small molecules
inferred← citeshttps://doi.org/10.1007/s10822-026-00798-2openalex-snapshot
AI-driven drug–target interaction prediction: current progress, challenges, and future roadmap for precision medicine
inferred← citeshttps://doi.org/10.1007/s40259-023-00611-8openalex-snapshot
Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management
inferred← citeshttps://doi.org/10.1016/j.artmed.2025.103195openalex-snapshot
ContraDTI: Improved drug–target interaction prediction via multi-view contrastive learning
inferred← citeshttps://doi.org/10.1016/j.bbagen.2020.129545openalex-snapshot
Machine learning and ligand binding predictions: A review of data, methods, and obstacles
inferred← citeshttps://doi.org/10.1016/j.chmed.2020.05.006openalex-snapshot
How to identify “Material basis–Quality markers” more accurately in Chinese herbal medicines from modern chromatography-mass spectrometry data-sets: Opportunities and challenges of chemometric tools
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2026.111832openalex-snapshot
Integrating experimental biology, computational methods, and artificial intelligence in anticancer drug discovery: Bridging the translational gap
inferred← citeshttps://doi.org/10.1016/j.crmeth.2025.101184openalex-snapshot
In silico methods for drug-target interaction prediction
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.03.025openalex-snapshot
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
inferred← citeshttps://doi.org/10.1016/j.csbj.2024.03.015openalex-snapshot
Databases of ligand-binding pockets and protein-ligand interactions
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.07.026openalex-snapshot
Advances in the computational landscape for repurposed drugs against COVID-19
inferred← citeshttps://doi.org/10.1016/j.isci.2023.107646openalex-snapshot
Overfit deep neural network for predicting drug-target interactions
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.106055openalex-snapshot
Polypharmacology: The science of multi-targeting molecules
inferred← citeshttps://doi.org/10.1016/j.ygeno.2021.11.010openalex-snapshot
Comparative genomic analysis of hyper-ammonia producing Acetoanaerobium sticklandii DSM 519 with purinolytic Gottschalkia acidurici 9a and pathogenic Peptoclostridium difficile 630
inferred← citeshttps://doi.org/10.1038/s41416-022-02067-zopenalex-snapshot
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
inferred← citeshttps://doi.org/10.1038/s41467-022-35692-6openalex-snapshot
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
inferred← citeshttps://doi.org/10.1038/s41573-025-01164-xopenalex-snapshot
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
inferred← citeshttps://doi.org/10.1038/s41598-023-37456-8openalex-snapshot
AiKPro: deep learning model for kinome-wide bioactivity profiling using structure-based sequence alignments and molecular 3D conformer ensemble descriptors
inferred← citeshttps://doi.org/10.1039/d1dd00011jopenalex-snapshot
MPSM-DTI: prediction of drug–target interaction via machine learning based on the chemical structure and protein sequence
inferred← citeshttps://doi.org/10.1039/d6dd00196copenalex-snapshot
Advances in multi-scale computational approaches for kinase selectivity profiling
inferred← citeshttps://doi.org/10.1063/5.0121901openalex-snapshot
Application of omics and proteomics in fungi
inferred← citeshttps://doi.org/10.1080/17460441.2021.1883585openalex-snapshot
Artificial intelligence, machine learning, and drug repurposing in cancer
inferred← citeshttps://doi.org/10.1080/17460441.2024.2430955openalex-snapshot
Validation guidelines for drug-target prediction methods
inferred← citeshttps://doi.org/10.1088/1755-1315/537/1/012023openalex-snapshot
The Combination of YAKE and Language Processing for Unsupervised Term Extraction Ontology Learning
inferred← citeshttps://doi.org/10.1089/omi.2023.0173openalex-snapshot
Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer
inferred← citeshttps://doi.org/10.1093/bib/bbaa003openalex-snapshot
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
inferred← citeshttps://doi.org/10.1093/bib/bbaa288openalex-snapshot
A review on drug repurposing applicable to COVID-19
inferred← citeshttps://doi.org/10.1093/bib/bbab350openalex-snapshot
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments
inferred← citeshttps://doi.org/10.1093/bib/bbaf625openalex-snapshot
Data-driven strategies for drug repurposing: insights, recommendations, and case studies
inferred← citeshttps://doi.org/10.1093/bib/bby119openalex-snapshot
Interactive visual analysis of drug–target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing
inferred← citeshttps://doi.org/10.1093/bib/bbz122openalex-snapshot
An omics perspective on drug target discovery platforms
inferred← citeshttps://doi.org/10.1093/bioinformatics/btae496openalex-snapshot
Attention-based approach to predict drug–target interactions across seven target superfamilies
inferred← citeshttps://doi.org/10.1093/database/baab005openalex-snapshot
Extraction of causal relations based on SBEL and BERT model
inferred← citeshttps://doi.org/10.1093/database/baab068openalex-snapshot
Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
inferred← citeshttps://doi.org/10.1093/jamiaopen/ooac043openalex-snapshot
How can natural language processing help model informed drug development?: a review
inferred← citeshttps://doi.org/10.1093/nar/gkaa1084openalex-snapshot
Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
inferred← citeshttps://doi.org/10.1097/md.0000000000037591openalex-snapshot
Design of a multi-category drug information integration platform for intelligent pharmacy management: A needs analysis study
inferred← citeshttps://doi.org/10.1101/2022.08.22.504151openalex-snapshot
Model Choice Metrics to Optimize Profile-QSAR Performance
inferred← citeshttps://doi.org/10.1101/2024.07.03.601957openalex-snapshot
CPIExtract: A software package to collect and harmonize small molecule and protein interactions
inferred← citeshttps://doi.org/10.1101/2025.11.12.688093openalex-snapshot
Off-target mapping enhances selectivity of machine learning-predicted CK2 inhibitors
inferred← citeshttps://doi.org/10.1101/mcs.a004853openalex-snapshot
Case report for an adolescent with germline RET mutation and alveolar rhabdomyosarcoma
inferred← citeshttps://doi.org/10.1109/jbhi.2024.3384696openalex-snapshot
Redefining the Game: MVAE-DFDPnet's Low-Dimensional Embeddings for Superior Drug-Protein Interaction Predictions
inferred← citeshttps://doi.org/10.1109/jbhi.2024.3448455openalex-snapshot
Advancing Bioactivity Prediction Through Molecular Docking and Self-Attention
inferred← citeshttps://doi.org/10.1124/molpharm.120.000210openalex-snapshot
Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus
inferred← citeshttps://doi.org/10.1126/sciadv.abe4038openalex-snapshot
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
inferred← citeshttps://doi.org/10.1136/archdischild-2023-326521openalex-snapshot
Smartphone use and well-being of adolescent girls: a population-based study
inferred← citeshttps://doi.org/10.1145/3465398openalex-snapshot
A Survey on Applications of Artificial Intelligence in Fighting Against COVID-19
inferred← citeshttps://doi.org/10.1158/0008-5472.can-24-3840openalex-snapshot
A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.1177/1934578x261489046openalex-snapshot
Anticancer Mechanism of Thalictrum punduanum Root Extract Against Breast and Colorectal Cancer: A Network Pharmacology and Molecular Docking Simulation Insights
inferred← citeshttps://doi.org/10.1186/s12859-022-04768-xopenalex-snapshot
Using BERT to identify drug-target interactions from whole PubMed
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1015236/v1openalex-snapshot
Using BERT to identify drug-target interactions from whole PubMed
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3242419/v1openalex-snapshot
Drug-Protein Interaction Prediction via Multi-View Variational Autoencoder and Cascade Deep Forests
inferred← citeshttps://doi.org/10.33774/chemrxiv-2021-xzgstopenalex-snapshot
Leveraging molecular structure and bioactivity with chemical language models for drug design
inferred← citeshttps://doi.org/10.3389/fddsv.2026.1836983openalex-snapshot
Artificial intelligence for small-molecule chemical probe design: why drug-centric models may not transfer cleanly
inferred← citeshttps://doi.org/10.3389/fonc.2020.605386openalex-snapshot
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
inferred← citeshttps://doi.org/10.3390/app13095617openalex-snapshot
Drug–Target Interaction Deep Learning-Based Model Identifies the Flavonoid Troxerutin as a Candidate TRPV1 Antagonist
inferred← citeshttps://doi.org/10.3390/bios15030191openalex-snapshot
Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives
inferred← citeshttps://doi.org/10.3390/v12111325openalex-snapshot
Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model
inferred← citeshttps://doi.org/10.3892/etm.2025.12860openalex-snapshot
Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm
inferred← citeshttps://doi.org/10.48550/arxiv.2111.00611openalex-snapshot
R-BERT-CNN: Drug-target interactions extraction from biomedical literature
inferred← citeshttps://doi.org/10.7240/jeps.1834505openalex-snapshot
De-TarDis: Decoy-Target Discovery Database Integrating Off-Targets, Promiscuity, Adverse/Side-Effects, and Screening Panels via Reciprocal Rank Fusion for Safety Assessment
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.